2015
DOI: 10.4254/wjh.v7.i11.1509
|View full text |Cite
|
Sign up to set email alerts
|

Current developments in pediatric liver transplantation

Abstract: In 1953, the pioneer of human orthotopic liver transplantation (LT), Thomas E Starzl, was the first to attempt an orthotopic liver transplant into a 3 years old patient suffering from biliary atresia. Thus, the first LT in humans was attempted in a disease, which, up until today, remains the main indication for pediatric LT (pLT). During the last sixty years, refinements in diagnostics and surgical technique, the introduction of new immunosuppressive medications and improvements in perioperative pediatric care… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
64
0
5

Year Published

2016
2016
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 68 publications
(73 citation statements)
references
References 103 publications
3
64
0
5
Order By: Relevance
“…Adolescents receiving liver transplants have excellent long‐term survival rates, with >80% surviving more than 10 years, which is comparable to younger children and better than adult population . Nevertheless, it is important to identify and predict survival in those adolescents who have higher risk of mortality or graft loss in the immediate post‐transplant period using a post‐transplant survival scoring system.…”
Section: Discussionmentioning
confidence: 99%
“…Adolescents receiving liver transplants have excellent long‐term survival rates, with >80% surviving more than 10 years, which is comparable to younger children and better than adult population . Nevertheless, it is important to identify and predict survival in those adolescents who have higher risk of mortality or graft loss in the immediate post‐transplant period using a post‐transplant survival scoring system.…”
Section: Discussionmentioning
confidence: 99%
“…In Japan, from November 1989 to December 2015, 2085 patients with BA underwent LDLT, and the rates of 1-year, 5-year, 10-year, 15-year, and 20-year graft survival for the patients with BA were high 24. In addition to the technical progress, there were also associated change of the primary disease of pediatric recipients of LT, that is, the main indications for LT in children are congenital and metabolic disease 25. Besides, the 2016 annual report from the Scientific Registry of Transplant Recipients demonstrated 90.8% 1-year and 82.7% 5-year graft survival among pediatric liver transplant recipients 26.…”
Section: Introductionmentioning
confidence: 99%
“…Liver transplantation is a well‐established treatment and a standard of care for children with end‐stage liver disease and liver‐based metabolic diseases. Improved surgical techniques, modern immunosuppressive regimens and highly developed peri‐ and postoperative intensive care increased success rates for long‐term patient survival up to 90% . Despite excellent survival rates, complications after pLT still occur.…”
Section: Introductionmentioning
confidence: 99%